Hospital Universitario Fundacion Jimenez Diaz — Clinical Trial Site

763 Registered trials

309 Currently recruiting

Organisation

Hospital Universitario Fundacion Jimenez Diaz

Location

Madrid, Spain

Identifier

ORG-100028994

Address

Avenida De Los Reyes Catolicos 2, 28040, Spain

Departments

-
#03402 :Oncología
#11101:Neurology
#1703: Oncologia
#2006:Oncology
#2243; Nefrología
#2309:servicio de neurología
#2410: Neurología
#2504: Servicio de oncología
#2609: Urology
#3101:Oncología médica
#3277:Urologia
#4205:Servicio de Cardiología
#6001: Servicio Oncología
#6002:Oncología
#7002:Medical Oncology
#7005: Oncología Médica
#7017:Dermatología
034027: Oncología
1311: Hematología y Hemoterapia
1603 :Oncología
172415: Hematología
3008:Traumatología
3108: neurologia
3122: medicina interna
3312: Oncología
3604; Oncología Médica
4205: Cardiólogos
5512: Neumología
600 : Oncología
6004:Oncologia Médica
7001: Hematología y Hemoterapia
7002: Oncología
7003: Ensayos clínicos Hematología
7004: Phase I Clinical Trials Unit
7005: Oncología Medica
7012:Oncología Médica
7117:Oncología
7208: Neurology
724003:Oncología
9001: Hematología
9409:Oncología
Alergology
Allergy
Allergy Department
Calvo
Cardiología
Cardiology
Cardiology Department
Cirugía
Clinical Hematology
Coloproctología
Departamento de Ginecología
Department of Medical Oncology, Oncohealth Institute
department of Nephrology
Department of Oncology
Department of Ophthalmology, Fundación Jiménez Díaz University Hospita
Department of surgery
Dermatologia
Dermatology
Digestive
Digestive. Gastroenterology. Endoscopy.
Early Phase 1 UNIT
Early Phase Clinical Trial Unit
Endocrinology
Endocrinology and metabolism
Enfermedades Infecciosas
ES30010: Hematología y Hemoterapia
ESP001: Oncología
Fundacion Jimenez Diaz( #1)
Gastroenterologist
Gastroenterology
Gastroenterology and Hepatology
General and Digestive Surgery.
Ginecología
Gynecology
Haematology
Haematology and Hemotherapy
Haematology Service
Head of Immunization Department
Hematolgy
Hematología
Hematology
Hematology and Hemotherapy
Hematology and Hemotherapy Service
Hematology Department
hematology service
Hematololgy
Hospital Universitario Fundación Jiménez Díaz
Infectious department
Infectious disease
Infectious Diseases
Intensive Care medicine
Internal Medicine
Internal Medicine - Diabetioloy
Internal Medicine department-Infectious diseases
Internal Medicine Service
Lymphoma department
Lymphoma Unit
Medica Oncology
Medical Oncology
Medical Oncology Department
Medical Oncology Service
Medicina Nuclear
N/A
NA
Nefrologia
Nefrología e Hipertensión
Nefrology
Nephorogy Service
Nephrology
Nephrology and Hypertension Department
Nephrology Service
Neprology
NEUMOLOGÍA
Neumology
Neurología
Neurology
Neurology Department
Not applicable
Obstetrics and Gynecology
Oftalmologia
Onccology
Oncolgy
Oncologia
Oncología Médica
Oncología Radioterápica
Oncología, 504
Oncología, Unidad de Fase 1
Oncology
Oncology – Phase 1 Clinical Trials
Oncology & Hematology
Oncology Department
Oncology Medicine
Oncology Service
Oncology, Start Madrid-FJD, Hospital Fundacion Jimenez Diaz
Ophthalmology
Orthopaedic Surgery and Traumatology
Otorhinolaryngolog Service
Otorhinolaryngology
Pediatric Endocrinology
Pediatric Gastroenterologist
Pediatrics department
Peritoneal Oncology Surgery
Phase I Clinical Trials
Phase I Clinical Trials Unit
Pneumology
Preventive Medicine
Preventive medicine and public health service
Pulmonology
Research Facility
Respiratory medicine
Reumatología
Rheumatology
Servicio de Endocrinología y Nutrición
Servicio de Enfermedades Infecciosas
Servicio de Hamatologia
Servicio de Hematología
Servicio de Infecciosas
Servicio de Medicina Interna
Servicio de Medicina Preventiva
Servicio de Nefrología, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Servicio de Neumología
Servicio de Neurologia
Servicio de Oftalmologia
Servicio de Oncologia
Servicio de Oncología médica
Servicio de Otorrinolaringología
Servicio de Reumatología
Servicio de Urología
Servicio Enfermedades Infecciosas
Servicio oftalmologia
START
START - Madrid -FJD
START Madrid
START Madrid - FJD
Start Madrid - Phase I Unit
START Madrid FJD.Phase 1 Trials
START Madrid-FJD
START Madrid-FJD, Hospital Fundacion Jimenez Diaz
START Madrid-FJD, Phase I Clinical Trials Unit
Start Madrid-Hematology
Start Unit
Start_Oncology
START-FJD, Early Phase Clinical Trials Unit
Surgery and New Therapies Laboratory
Thoracic Oncology
Unidad de Enfermedades Infecciosas
Unidad de Ensayos Clínicos Fase I
Unidad de ensayos clínicos, fase 1
Unidad de Ensayos Fase I
Unidad Ensayos Fase I - Oncology
Unidad START-Madrid FJD
Urologia
Urology

Clinical trials at this site (763)

Search interface

A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY OF CLN-049 FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH M… Recruiting

2023-506572-27-00 Acute Myeloid Leukemia (AML) with Measurable Residual D 3 2024-01-12
A trial to learn if odronextamab combined with lenalidomide is safe and works better than rituximab combined with lenalidomide in adult part… Recruiting

2022-503092-28-00 Relapsed/Refractory Follicular Lymphoma 5 2024-01-08
A study of STX-478 alone and in combination with other anticancer drugs in participants with advanced solid tumors. Recruiting

2023-504807-94-00 Breast Cancer; Advanced solid tumors including but not 7 2023-12-26
A Phase 1, Open-Label, Multicenter Study of INCA033890 in Participants with Advanced or Metastatic Solid Tumors Recruiting

2022-502456-31-00 Advanced or metastatic solid tumors 1 2023-11-30
FOENIX-CCA4 Recruiting

2023-503665-39-00 Advanced cholangiocarcinoma 4 2023-11-14
177Lu-edotreotide compared to everolimus in neuroendocrine tumors of the lung and thymus Recruiting

2022-502154-13-00 Patients with well to moderately differentiated neuroen 5 2023-10-27
Biomarker analysis in patients with metastatic breast cancer treated with sacituzumab govitecan. Recruiting

2023-505385-28-00 male or pre/post-menopausal women age ≥ 18 years with l 4 2023-10-19
A Modular, Multi-part, Multi-arm, Open-label, Phase I/II Study to Evaluate the Safety and Tolerability of GRWD5769 Alone and in Combination … Recruiting

2023-504845-30-00 Solid malignancies 7 2023-10-05
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Recruiting

2024-518844-20-00 Treatment of Acute Gout Flare 10 2023-10-03
Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) Recruiting

2022-502281-25-00 Focal Onset Seizures 5 2023-09-27
A Study Evaluating the Overall Survival of Patients with Extensive Stage Small Cell Lung Cancer Receiving Trilaciclib or Placebo prior to To… Recruiting

2022-502357-34-00 Extensive Stage Small Cell Lung Cancer 5 2023-09-27
A Dose Escalation and Expansion Study of BGB-16673 in Patients with B Cell Malignancies Recruiting

2022-502157-33-00 B-Cell Malignancies 7 2023-09-18
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given with Either Cemiplimab, or Cemiplimab + Fianlimab, … Recruiting

2022-501904-83-00 Ovarian Cancer 7 2023-09-11
Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo i… Recruiting

2024-510959-35-00 Parkinson's disease 4 2023-09-07
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR) Recruiting

2024-513562-19-00 End-Stage Kidney Disease 5 2023-08-30
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination with Checkpoint Inhibitor i… Recruiting

2023-504709-35-00 Locally advanced or metastatic solid tumors 1 2023-08-16
First-in-human, Phase 1/2, open-label, multicenter, dose-escalation and expansion study Recruiting

2022-502645-99-00 MTAP-deleted Advanced or Metastatic Solid Tumors 7 2023-08-09
A Study of Debio 0123 in Combination with Temozolomide in Adult Participants with Recurrent or Progressive Glioblastoma and of Debio 0123 in… Recruiting

2022-502156-31-00 Glioblastoma 9 2023-05-26
Clinical trial of androgen deprivation therapy combined with salvage radiotherapy when treating prostate cancer that has suffered recurrence… Recruiting

2024-517666-41-00 Prostate Cancer 5 2023-03-13
Combined treatment of intraperitoneal chemotherapy after optimal interval surgery in advanced ovarian cancer. BICOV-1 (Bidirectional Chemoth… Recruiting

2022-502691-23-00 Ovarian cancer 6 2023-02-27
Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors Recruiting

2024-513056-15-00 Advanced Solid Tumors 7 2022-12-01
Clinical study to test the safety, tolerance and preliminary efficacy of oral ITF3756 administered alone or in combination with an anti-prot… Recruiting

2022-501089-22-00 Advanced solid tumors 1 2022-11-29
A First-in-Human Dose Escalation Study of JNJ-79635322, in Participants with Relapsed or Refractory Multiple Myeloma or Previously Treated A… Recruiting

2023-503679-12-00 Relapsed or Refractory Multiple Myeloma 1 2022-11-21